基于目标结节大小的经皮肺活检诊断效能与并发症率评估
本单中心回顾性研究纳入2019年1月1日至2020年6月30日所有门诊经皮肺活检,记录目标结节大小、位置、诊断效能与并发症率。诊断率随结节增大而升高,ROC分析提示预测诊断性样本的最佳阈值大小为1.4 cm;气胸率随目标结节减小而显著升高,但目标大小与需胸管置入或住院无显著关联。
要点
- 诊断率随结节增大而升高,ROC分析提示预测诊断性样本的最佳阈值大小为1.4 cm。
- 气胸率随目标结节减小而显著升高。
- 目标结节大小与需胸管置入或住院无显著关联。
核心结论
- 肺结节越小,越难获得诊断性样本,且越容易发生活检后气胸;但较小目标尺寸与胸管置入或住院风险增加无关。
研究设计与样本
- 单中心回顾性研究,回顾2019年1月1日至2020年6月30日所有门诊经皮肺活检,记录目标结节大小、位置、诊断效能与并发症率。
诊断标准与关键数值
- 诊断率随结节增大而升高,ROC分析提示预测诊断性样本的最佳阈值大小为1.4 cm。
- 气胸率随目标结节减小而显著升高。
- 目标结节大小与需胸管置入或住院无显著关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Percutaneous lung biopsies are a common radiologic procedure, although they are not without risk. As imaging techniques continue to increase in sophistication, referring providers may request lung biopsies on smaller and smaller targets. Our purpose is to better understand when we should expect lung biopsies to yield diagnostic results of lung nodules of varying sizes and how size impacts the complication rate of the procedure.
METHODS: We retrospectively reviewed all outpatient lung biopsies performed at our institution between January 1, 2019, and June 30, 2020. For all procedures, target nodule size, location, diagnostic performance, and complication rates were recorded.
RESULTS: We found that diagnostic yield increased with increasing nodule size, with ROC analysis indicating that the best threshold size to predict a diagnostic sample is 1.4 cm. Pneumothorax rate significantly increased with decreasing target size, but there was no significant association between target size and the need for either chest tube placement or hospital admission.
CONCLUSION: The smaller a lung nodule is, the harder it is to obtain a diagnostic sample, and the more likely it is to develop a post-biopsy pneumothorax. However, smaller target size is not associated with an increased risk of chest tube placement or hospital admission.
引用
- W Bowman A, Li Z. Assessment of diagnostic performance and complication rate in percutaneous lung biopsy based on target nodule size. Abdom Radiol (NY). 2024. PMID: 39465415. doi:10.1007/s00261-024-04648-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。